Emergent BioSolutions (EBS) Cash & Equivalents (QoQ) (2010 - 2026)
Emergent BioSolutions (EBS) Cash & Equivalents (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.95 Bn | 88.09 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.20 Bn | 1.97 Bn |
| 3 | Zoetis | 32.60 Bn | 30.66 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.07 Bn | 20.91 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.35 Bn | 18.55 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.47 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.63 Bn | 12.20 Bn | 785.00 Mn |
| 10 | Emergent BioSolutions | 384.58 Mn | 223.08 Mn | 84.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.96% |
| Dec 31, 2025 | -16.33% |
| Sep 30, 2025 | -8.16% |
| Jun 30, 2025 | 79.28% |
| Mar 31, 2025 | 49.85% |
| Dec 31, 2024 | -33.62% |
| Sep 30, 2024 | 115.06% |
| Jun 30, 2024 | -11.21% |
| Mar 31, 2024 | -29.72% |
| Dec 31, 2023 | 27.22% |
| Sep 30, 2023 | -0.90% |
| Jun 30, 2023 | -79.40% |
| Mar 31, 2023 | -33.05% |
| Dec 31, 2022 | 166.75% |
| Sep 30, 2022 | -32.73% |
| Jun 30, 2022 | -17.83% |
| Mar 31, 2022 | -24.35% |
| Dec 31, 2021 | 42.67% |
| Sep 30, 2021 | -9.77% |
| Jun 30, 2021 | -18.31% |